TIAA Trust, National Association’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$198K Sell
8,240
-3,329
-29% -$87.1K 0.01% 184
2026
Q1
$325K Sell
11,569
-290,345
-96% -$7.73M 0.02% 205
2025
Q4
$7.52M Sell
301,914
-14,113
-4% -$356K 0.02% 207
2025
Q3
$8.05M Sell
316,027
-14,655
-4% -$362K 0.02% 208
2025
Q2
$8.02M Sell
330,682
-42,023
-11% -$980K 0.02% 202
2025
Q1
$9.44M Sell
372,705
-32,535
-8% -$851K 0.03% 184
2024
Q4
$10.8M Sell
405,240
-41,107
-9% -$1.12M 0.03% 175
2024
Q3
$12.9M Buy
446,347
+19,164
+4% +$559K 0.04% 162
2024
Q2
$12M Sell
427,183
-18,208
-4% -$501K 0.04% 167
2024
Q1
$12.4M Sell
445,391
-37,733
-8% -$1.05M 0.04% 168
2023
Q4
$13.9M Sell
483,124
-46,000
-9% -$1.39M 0.05% 151
2023
Q3
$17.6M Buy
+529,124
New +$18.7M 0.06% 120

Other funds holding PFE

TIAA Trust, National Association's PFE Position: Q2 2026 in Review

TIAA Trust, National Association reduced its Pfizer (PFE) stake by 29% in Q2 2026, selling an estimated $87.1K and leaving 8,240 shares worth $198K. The position accounts for 0.01% of the portfolio, ranked #184.

TIAA Trust, National Association first reported a position in PFE in Q3 2023 and has held it in 12 quarters since. The position peaked at $17.6M in Q3 2023. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • TIAA Trust, National Association held 8,240 shares of Pfizer worth $198K as of Q2 2026.
  • TIAA Trust, National Association sold 3,329 Pfizer shares in Q2 2026, an estimated $87.1K.
  • Pfizer made up 0.01% of TIAA Trust, National Association's portfolio in Q2 2026, its #184 holding.
  • TIAA Trust, National Association first reported a position in Pfizer in Q3 2023 and has held it in 12 quarters since.
  • TIAA Trust, National Association's Pfizer position peaked at $17.6M in Q3 2023.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on TIAA Trust, National Association's 13F filing for Q2 2026, filed 10 Aug 2026.